David Jeevan is an Honorary Clinical Research Fellow. He is also a Senior Registrar (ST6) in Obstetrics & Gynaecology. He was awarded the prestigious Wellbeing of Women Research Training Fellowship in 2017 following a year of research funded by the Institute of Translational Medicine.
David’s interest is using mass spectrometry and steroid metabolomics to improve diagnosis and therapy of ovarian cancer. He is based at the Department of Metabolism and Systems Science.
Ovarian cancer carries a lifetime risk of 1 in 52 in all women. In the UK, over 4000 women die from the disease annually. Survival is extremely poor because the disease is often detected at a late stage and current therapy is very limited; hence there is an urgent unmet need to develop new tests and treatments.